More on Boston Scientific (BSX -2.5%) Q3: swings to net loss of $725M from a net profit of $142M...

|About: Boston Scientific Corpora... (BSX)|By:, SA News Editor

More on Boston Scientific (BSX -2.5%) Q3: swings to net loss of $725M from a net profit of $142M a year ago, with the latest results including charges of $946M. Expects Q4 adjusted EPS of $0.15-$0.18 on sales of $1.74B-$1.815B vs. consensus of $0.12 and $1.8B respectively. Narrows FY forecasts to EPS of $0.63-$0.66 on revenue of $7.17B-$7.24B vs. $0.42 and $7.26B.